Krystal Share Price

Krystal Share Price

NASDAQ: KRYS | Mid Cap | Healthcare
$308.81
-$7.21 (-2.28%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Krystal Stock Performance

Open
$318.45
Prev. Close
$316.02
Circuit Range
N/A
Day Range
$308.39 - $320.70
Year Range
$203.62 - $382.01
Volume
11,996
Average Traded
$312.21

Krystal Share Price Today

As of 22 November 2026, Krystal Biotech, Inc.'s share price is $308.81. The stock opened at $318.45, compared to its previous close of $316.02. During today's trading session, Krystal Biotech, Inc.'s share price traded between $308.39 and $320.70, with an average price of $314.54. Over the past 52 weeks, the stock has recorded a high of $382.01 and a low of $203.62. In terms of performance, Krystal Biotech, Inc.'s share price has declined by 0.11% over the last six months and is up 42.16% on a year-on-year basis.

Krystal Share Price Chart

Line chart of the Krystal price trend over the selected period. The price fell overall, ranging from 308.65 to 320.70, ending at 308.81.
$308.39$320.70
L
Show Current Price
H

Krystal Stock Fundamentals & Key Indicators

Market Cap
$8.94B
PE Ratio (TTM)
40.65
Dividend Yield
0.00%
EPS (TTM)
$7.60
Revenue (TTM)
$389.13B
Return On Equity (TTM)
15.68%
Profit Margin
52.64%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
22.70%

Krystal Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$107.11$116.36$119.22$127.34
Net Profit$51.40$55.93$54.77$63.07
Net Profit Margin47.99%48.07%45.94%49.53%
Income ChangeN/A8.81%-2.07%15.15%

Krystal Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$50.70$290.52$389.13
Net Profit-$139.98$10.93$89.16$204.83
Net Profit MarginN/A21.56%30.69%52.64%
Income ChangeN/A107.81%715.74%129.73%

Krystal Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets309.19313.79230.45174.67
Current Assets1024.6742.05587.91383.78
Total Assets1333.791055.84818.36558.45
Non Current Liabilities11.297.466.627.37
Current Liabilities102.94102.033.0928.85
Total Liabilities114.23109.4639.7136.22
Shareholders' Equity1219.56946.38778.64522.23

Krystal Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating200.87123.42-88.8-100.57
Investing-58.42-163.4482.64-114.08
Financing8.7127.01202.7535.35

About Krystal

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Krystal Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$317.00
$308.83
-6.86%
Oct 2026
$330.56
$331.59
-0.54%
Sep 2026
$360.80
$333.38
-6.74%
Aug 2026
$322.00
$357.49
+4.81%
Jul 2026
$369.77
$341.08
-8.25%
Jun 2026
$306.16
$371.74
+20.25%
May 2026
$263.03
$309.14
+17.80%
Apr 2026
$258.50
$262.42
+1.79%
Mar 2026
$267.50
$257.81
-6.37%
Feb 2026
$279.99
$275.35
-1.38%
Jan 2026
$245.06
$279.19
+12.87%
Dec 2025
$213.98
$247.35
+13.87%

Krystal Share Price FAQs